Kimia Biosciences touches roof on getting recognition for supply of Bilastine to Bangladesh
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Kimia Biosciences is currently trading at its upper circuit limit of Rs. 56.00, up by 9.30 points or 19.91% from its previous closing of Rs. 46.70 on the BSE.
The scrip opened at Rs. 49.10 and has touched a high and low of Rs. 56.00 and Rs. 49.10 respectively. So far 71941 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 64.45 on 06-Jan-2021 and a 52 week low of Rs. 35.20 on 29-Nov-2021.
Last one week high and low of the scrip stood at Rs. 56.00 and Rs. 37.05 respectively. The current market cap of the company is Rs. 264.95 crore.
The promoters holding in the company stood at 74.94%, while Institutions and Non-Institutions held 0.38% and 24.68% respectively.
Kimia Biosciences has been recognized for supply of pharmaceutical raw material (Bilastine) to Bangladesh by Directorate General of Drug Administration & Licensing Authority (Drugs), Govt. of the people's republic of Bangladesh. This certificate of source validation is valid for 3 years from date of issue.
Kimia Biosciences is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.
